90 related articles for article (PubMed ID: 7687918)
1. A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Liang JC; Bailey NM; Gabriel GJ; Kattan MW; Wang RY; Hagemeister FB; Cabanillas FF; Fuller LM
Leuk Lymphoma; 1993 Apr; 9(6):503-8. PubMed ID: 7687918
[TBL] [Abstract][Full Text] [Related]
2. Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Sen P; Bailey NM; Hagemeister FB; Liang JC
Cancer Res; 1990 Feb; 50(3):558-62. PubMed ID: 1688733
[TBL] [Abstract][Full Text] [Related]
3. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Meistrich ML; Wilson G; Mathur K; Fuller LM; Rodriguez MA; McLaughlin P; Romaguera JE; Cabanillas FF; Ha CS; Lipshultz LI; Hagemeister FB
J Clin Oncol; 1997 Dec; 15(12):3488-95. PubMed ID: 9396402
[TBL] [Abstract][Full Text] [Related]
4. Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy.
Tormo M; Terol MJ; Marugán I; Solano C; Benet I; Garcia-Conde J
Leuk Lymphoma; 1999 Jun; 34(1-2):137-42. PubMed ID: 10350341
[TBL] [Abstract][Full Text] [Related]
5. NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Hagemeister FB; Cabanillas F; Velásquez WS; Meistrich ML; Liang JC; McLaughlin P; Redman JR; Romaguera JE; Rodríguez MA; Swan F
Semin Oncol; 1990 Dec; 17(6 Suppl 10):34-8; discussion 38-40. PubMed ID: 2259922
[TBL] [Abstract][Full Text] [Related]
6. NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21.
Frias S; Van Hummelen P; Meistrich ML; Lowe XR; Hagemeister FB; Shelby MD; Bishop JB; Wyrobek AJ
Cancer Res; 2003 Jan; 63(1):44-51. PubMed ID: 12517776
[TBL] [Abstract][Full Text] [Related]
7. NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Hagemeister FB; Fuller L; McLaughlin P; Rodriguez M; Romaguera J; Swan F; Cabanillas F
Ann Oncol; 1992 Sep; 3 Suppl 4():87-90. PubMed ID: 1450086
[TBL] [Abstract][Full Text] [Related]
8. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B
J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
11. Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).
Dubey P; Wilson G; Mathur KK; Hagemeister FB; Fuller LM; Ha CS; Cox JD; Meistrich ML
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):609-17. PubMed ID: 10701740
[TBL] [Abstract][Full Text] [Related]
12. Are alkylating agents a necessary component in the therapy of Hodgkin's disease.
Hagemeister FB
Leuk Lymphoma; 1993; 10 Suppl():91-7. PubMed ID: 7683230
[TBL] [Abstract][Full Text] [Related]
13. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
Glick JH; Young ML; Harrington D; Schilsky RL; Beck T; Neiman R; Fisher RI; Peterson BA; Oken MM
J Clin Oncol; 1998 Jan; 16(1):19-26. PubMed ID: 9440718
[TBL] [Abstract][Full Text] [Related]
14. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
[TBL] [Abstract][Full Text] [Related]
15. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
16. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Gobbi PG; Pieresca C; Federico M; Di Renzo N; Narni F; Iannitto E; Grignani G; Cavanna L; Avanzini P; Partesotti G
J Clin Oncol; 1993 Apr; 11(4):712-9. PubMed ID: 7683044
[TBL] [Abstract][Full Text] [Related]
17. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
18. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
19. Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Canellos GP; Petroni GR; Barcos M; Duggan DB; Peterson BA
J Clin Oncol; 1995 Aug; 13(8):2005-11. PubMed ID: 7636541
[TBL] [Abstract][Full Text] [Related]
20. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
